Mucosal TLR5 Activation Controls Healthspan and Longevity

    January 2024 in “ Nature communications
    J. Lim, Eun Jae Jeon, Hye Sun Go, Hyungjin Kim, Kye Young Kim, Thi Quynh Trang Nguyen, D. Lee, Kyu Suk Kim, Federico Pietrocola, Seol Hee Hong, Shee Eun Lee, Kyoung‐Shim Kim, Tae‐Shin Park, Dong‐Hee Choi, Yu‐Jin Jeong, Jong‐Hwan Park, Hyeon Sik Kim, Jung‐Joon Min, Yong Sook Kim, Joon Tae Park, Jae-Ho Cho, Gil-Woo Lee, Ji Hyeon Lee, Hyon E. Choy, Sang Chul Park, Chul‐Ho Lee, Joon Haeng Rhee, Manuel Serrano, Kyung A Cho
    Image
    Studysummary This study found that stimulating toll-like receptor 5 via mucosal delivery of a flagellin-containing fusion protein effectively extended lifespan and enhanced healthspan in mice, including improved bone density and cognitive capacity.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →